These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39209505)

  • 21. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
    Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
    Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
    J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
    Woelber L; Griebel LF; Eulenburg C; Sehouli J; Jueckstock J; Hilpert F; de Gregorio N; Hasenburg A; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann KH; Thiel FC; Mustea A; Meier W; Harter P; Wimberger P; Hanker LC; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Neuser P; Mahner S
    Eur J Cancer; 2016 Dec; 69():180-188. PubMed ID: 27837710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of lymph node ratio and number of positive inguinal nodes in patients with vulvar cancer.
    Polterauer S; Schwameis R; Grimm C; Macuks R; Iacoponi S; Zalewski K; Zapardiel I;
    Gynecol Oncol; 2017 Oct; 147(1):92-97. PubMed ID: 28797698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinical versus surgical staging systems in vulvar cancer.
    Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
    Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of surgical treatment of vulvar cancer].
    Kreienberg R; Beck T; Bartzke G; Henne M; Friedberg F
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):375-82. PubMed ID: 2373335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in of late-stage squamous cell vulvar carcinomas: analysis of the surveillance, epidemiology, and end results (SEER) database.
    Ramanah R; Lesieur B; Ballester M; Darai E; Rouzier R
    Int J Gynecol Cancer; 2012 Jun; 22(5):854-9. PubMed ID: 22426405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.
    Yasunaga M; Yahata H; Okugawa K; Hori E; Kodama K; Yagi H; Ohgami T; Onoyama I; Asanoma K; Kato K
    Int J Clin Oncol; 2021 Jul; 26(7):1330-1335. PubMed ID: 33786711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vulvar cancer: surgical management and survival trends in a low resource setting.
    Kumar N; Ray MD; Sharma DN; Pandey R; Lata K; Mishra A; Wankhede D; Saikia J
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):4. PubMed ID: 32372283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the FIGO 2009 staging system for carcinoma of the vulva.
    Tan J; Chetty N; Kondalsamy-Chennakesavan S; Crandon A; Garrett A; Land R; Nascimento M; Nicklin J; Perrin L; Obermair A
    Int J Gynecol Cancer; 2012 Mar; 22(3):498-502. PubMed ID: 22367324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio has prognostic value related to the number of positive lymph nodes in patients with vulvar cancer.
    Wu SG; Zhang WW; Li FY; Sun JY; Zhou J; He ZY
    Future Oncol; 2018 Oct; 14(23):2343-2351. PubMed ID: 29807463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midline involvement as a risk factor for vulvar cancer recurrence.
    Stankevica J; Macuks R; Baidekalna I; Donina S
    Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic characteristics, recurrence patterns, and survival outcomes of vulval squamous cell carcinoma - A twelve-year retrospective analysis of a tertiary centre.
    Darwish A; Ismail L; Manek S; Hellner K; Kehoe S; Soleymani Majd H
    Eur J Surg Oncol; 2024 Jul; 50(7):108447. PubMed ID: 38843661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma.
    Dai YF; Xu M; Zhong LY; Xie XY; Liu ZD; Yan MX; Yi H; Lin DM
    J Int Med Res; 2018 Oct; 46(10):4082-4091. PubMed ID: 29963935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
    Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
    Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.